Abu-Hejleh T - Search Results

1

Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers.

Abu-Hejleh T, Mezhir JJ, Goodheart MJ, Halfdanarson TR. Abu-Hejleh T, et al. Curr Oncol Rep. 2012 Aug;14(4):277-84. doi: 10.1007/s11912-012-0238-8. Curr Oncol Rep. 2012. PMID: 22532266 Review.

2

Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature.

Leon-Ferre RA, Abu Hejleh TB, Halfdanarson TR. Leon-Ferre RA, et al. Clin Adv Hematol Oncol. 2012 Aug;10(8):546-8. Clin Adv Hematol Oncol. 2012. PMID: 23073056 Review. No abstract available.

3

The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer.

Abu-Hejleh T, Chrischilles EA, Halfdanarson TR, Simon C, Pendergast JF, Jiang D, Smith CJ, Porter AT, Carter KD, Wallace RB; Cancer Care Outcomes Research and Surveillance Consortium (CanCORS). Abu-Hejleh T, et al. Am J Clin Oncol. 2016 Apr;39(2):126-31. doi: 10.1097/COC.0000000000000029. Am J Clin Oncol. 2016. PMID: 24632817 Free PMC article.

4

Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.

Schroeder MC, Tien YY, Wright K, Halfdanarson TR, Abu-Hejleh T, Brooks JM. Schroeder MC, et al. Lung Cancer. 2016 May;95:28-34. doi: 10.1016/j.lungcan.2016.02.010. Epub 2016 Feb 23. Lung Cancer. 2016. PMID: 27040848 Free PMC article.

5

Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients.

Abu Hejleh T, Deyoung BR, Engelman E, Deutsch JM, Zimmerman B, Halfdanarson TR, Berg DJ, Parekh KR, Lynch WR, Iannettoni MD, Bhatia S, Clamon G. Abu Hejleh T, et al. World J Gastrointest Oncol. 2012 May 15;4(5):103-8. doi: 10.4251/wjgo.v4.i5.103. World J Gastrointest Oncol. 2012. PMID: 22645633 Free PMC article.

6

Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study.

Schroeder MC, Chapman CG, Nattinger MC, Halfdanarson TR, Abu-Hejleh T, Tien YY, Brooks JM. Schroeder MC, et al. BMC Health Serv Res. 2016 Jul 18;16:274. doi: 10.1186/s12913-016-1549-5. BMC Health Serv Res. 2016. PMID: 27430623 Free PMC article.

7

Advances in the systemic treatment of leptomeningeal cancer.

Abu Hejleh T, Clamon G. Abu Hejleh T, et al. Clin Adv Hematol Oncol. 2012 Mar;10(3):166-70. Clin Adv Hematol Oncol. 2012. PMID: 22402424 Review.

8

Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.

Schroeder MC, Lynch CF, Abu-Hejleh T, Chrischilles EA, Thomas A. Schroeder MC, et al. Clin Breast Cancer. 2015 Feb;15(1):e27-34. doi: 10.1016/j.clbc.2014.07.009. Epub 2014 Aug 18. Clin Breast Cancer. 2015. PMID: 25245424 Free PMC article.

9

Germline mutations predisposing to non-small cell lung cancer.

Clamon GH, Bossler AD, Abu Hejleh T, Furqan M. Clamon GH, et al. Fam Cancer. 2015 Sep;14(3):463-9. doi: 10.1007/s10689-015-9796-x. Fam Cancer. 2015. PMID: 25813228 Review.

10

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

Swami U, Lenert P, Furqan M, Abu Hejleh T, Clamon G, Zhang J. Swami U, et al. J Thorac Oncol. 2018 Jun;13(6):e102-e103. doi: 10.1016/j.jtho.2018.01.027. J Thorac Oncol. 2018. PMID: 29793647 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page